Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
Status: Forecast, not open yet
- Who can apply
- Nonprofits, small businesses, state, local and tribal governments, tribes, schools and universities, for-profit companies, others.
- Deadline
- Expected around Jun 18, 2027 (forecast, not confirmed)
- Opened Aug 13, 2026
- Amount
- Not stated by the source
- Official source
- Read and apply at the official source Found on grants.gov
- Requirements
- See the official notice
- Organizations need a SAM.gov ID number (UEI) to apply. Individuals do not.
- Application fee
- We do not read fees from notices; check the official notice. GrantsWindow never charges you.
- Funder
- National Institutes of Health (federal)
- Assistance Listing 93.866
- Last checked
- Checked Nov 15, 2026 at the official source
From the official notice
The National Institute on Aging (NIA) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications that propose pre-clinical and early-stage clinical (Phase I) development of novel small-molecule and biologic drug candidates that aim to prevent Alzheimer's disease (AD), slow ...
Topics this may fit (our guess)
minority-serving